Catalyst Wire Dossier Catalyst Wire Dossier

Meningococcal ACWY-CRM vaccine

· Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Meningococcal ACWY-CRM vaccine, covering 2015-11-04 to 2015-11-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of One Dose of Novartis' Meningococcal ACWY-CRM Vaccine and GlaxoSmithKline Biologicals' Meningococcal ACWY-TT Vaccine in Healthy Toddlers [Phase 2]

See pricing